The volume change is totally insignificant, the dose did not change. What is significant is that the trial is no longer recruiting. There were only supposed to be 30 patients dosed, so it seems they are on track. They are in a data collection period now, getting results from those already doses. This phase will complete by August 2018 and we can expect results in 2019.
Market Data 
Markets 
AI
